Vivian Lee

Last updated

Vivian Lee
Vivian S. Lee M.D.jpg
BornSeptember 1966 (age 58)
Morristown, New Jersey, U.S.
Education Harvard University (BS, MD)
Balliol College, Oxford (MS, PhD)
New York University (MBA)
Awards National Academy of Medicine
Scientific career
Fields Radiology
Health administration
Education
Author
Research

Vivian S. Lee (born September 1966) is an American radiologist and health care/health technology executive. An Executive Fellow at Harvard Business School and senior lecturer at Harvard Medical School and Massachusetts General Hospital, Lee is the author of the book, The Long Fix: Solving America's Health Care Crisis with Strategies That Work for Everyone (W.W. Norton, 2020). Lee is also a senior fellow at the Institute for Healthcare Improvement (IHI) [1] in Cambridge, Massachusetts. In 2019, she was named No. 11 in Modern Healthcare's 100 Most Influential People in Healthcare [2] and is a frequent speaker at national and international meetings on the applications of big data, AI, and technology in healthcare, leadership and managing change, health equity, and on climate change and health system resilience.

Contents

Raised in Norman, Oklahoma and trained in biomedical engineering and medicine, Lee established an NIH-funded research program in magnetic resonance imaging at NYU. She was elected Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM) [3] in 2006 and served as the president in 2008–2009. For her scientific discoveries, she was elected to the American Society of Clinical Investigation [4] and the National Academy of Medicine. [5]

From 2018-2022, she was founding President of Health Platforms at Verily (Alphabet), launching and growing a number of successful health technology companies. Among her leadership roles in academic medicine, Lee served as the CEO of University of Utah Health, dean of the University of Utah School of Medicine and senior vice-president for health sciences of the University of Utah in Salt Lake City. [6] And before that as the inaugural chief scientific officer and vice dean for science at NYU Langone Medical Center. She is also a member of the scientific advisory boards of the Massachusetts General Hospital, [7] and previously served on the University of Pennsylvania's Center for Health Incentives & Behavioral Economics (CHIBE) External Advisory Board, [8] and on the Defense Health Board of the Department of Defense. She serves as Editor-at-Large for New England Journal of Medicine Catalyst. [9]

Lee has studied the management and improvement of health care, with an emphasis on data measurement and feedback to create learning health systems and her work has demonstrated the virtuous cycle of improved patient-centeredness, higher quality with better outcomes, and lower costs.

She is married to international legal scholar Benedict Kingsbury. [10] Lee also serves on the board of directors of the American Association of Rhodes Scholars and the Commonwealth Fund, and is also a director of Zions Bancorporation.

Education and training

A U.S. Presidential Scholar and National Merit Scholar, Lee graduated from Norman High School, in Norman, Oklahoma in 1983.

Lee graduated from Radcliffe College of Harvard University magna cum laude in 1986 before receiving a Rhodes Scholarship to study at Balliol College, Oxford where she received a doctorate in medical engineering. [11] She then earned an M.D. with honors from Harvard Medical School and subsequently completed a residency in diagnostic radiology at Duke University [11] and a fellowship in MRI at NYU Medical Center.

In 2006, she completed a Master of Business Administration degree at NYU's Stern School of Business, graduating as valedictorian. She later delivered the commencement speech for the class of 2017. [12]

Research in MRI

Funded initially while an MRI fellow and subsequently by the NIH, Lee's initial work developed methods to measure kidney glomerular filtration rate (GFR) and perfusion, noninvasively using ultra-low dose gadolinium-contrast enhanced MRI. [13] [14] These techniques were applied to the improved diagnosis of renovascular disease, [15] renal transplant dysfunction, [16] and renal function in cirrhosis. [17] Extensions of this work include the use of MR methods to measure tissue hypoxia [18] and tubular function. [19]

While a part of the NYU MRI research team, Lee contributed to multiple advances in clinical body MRI, including pioneering 3D (volumetric) liver imaging for routine clinical care and for improved detection of hepatocellular carcinoma, [20] improved methods for assessing vascular disease with 3D gadolinium-enhanced MR angiography [21] and venography, [22] and improved surgical planning for living related transplant donor planning in liver and kidney transplantation. [23] [24]

As the director of Cardiothoracic MR imaging at NYU, Lee developed new MR methods for fast cardiac imaging [25] and for improved detection of myocardial infarcts. [26] Subsequently, Lee's NIH funded research focused on the development of non-contrast-enhanced methods for vascular MR imaging, and functional calf muscle studies that assess exercise-induced "stress-rest" performance in patients with suspected peripheral vascular disease. [27] [28] [29]

A popular lecturer who has received multiple teaching awards, Lee authored a textbook entitled Cardiovascular MRI: Physical Principles to Practical Protocols (Lippincott 2006).

Administrative and leadership roles

NYU Langone Medical Center

During her 5-year tenure as vice-chair for research in radiology, Lee helped build a research administrative infrastructure that enabled the department, previously unranked in NIH research funding, to reach the top 20. [30] During that time, NYU Langone was also the first U.S. site to install a whole body 7 Tesla MRI scanner. [31]

In 2007, Lee became the inaugural vice dean for science, chief scientific officer and senior vice-president, serving as a member of NYU's executive leadership team. Initiatives as chief scientific officer included establishing a new philanthropically-funded Neurosciences Institute [32] and a new NIH-funded Center for Translational Science Institute (CTSI), [33] upgrading core facilities, educational initiatives in grantsmanship, and establishment of a new Center for Health Informatics and Bioinformatics [34] and a new department of statistics and epidemiology. During her four-year tenure, NYU's ranking among NIH-funded schools of medicine increased from No. 36 to No. 26, and continued to rise thereafter. [30]

International Society for Magnetic Resonance in Medicine (ISMRM)

While at NYU, Lee held a number of leadership positions in the ISMRM, the preeminent professional organization of clinical and research MR scientists. She served on the board of trustees from 2002 to 2010, president 2008–2009, and as Scientific Program Chair for 2005 Annual ISMRM meeting. During her tenure, the ISMRM increased financial reserves, enhanced clinician membership and supported sustainability efforts through new "virtual" meetings.

University of Utah

From 2011 to 2017, Lee served as senior vice-president for health sciences, dean of the school of medicine, and the CEO of University of Utah Health. Lee was responsible for an academic health sciences complex that includes five major schools (School of Medicine, School of Dentistry, and Colleges of Nursing, Pharmacy and Health) and a health care system comprising four hospitals, dozens of clinical and research specialty centers, a network of 12 Salt Lake City-area health centers, a regional affiliate network of 19 partner facilities, a health plan, and over 1,400 board-certified physicians. Under her leadership, the University of Utah established a new School of Dentistry, the first new academic dental school in the nation in over 25 years, graduating its first class in 2017. [35]

Lee led University of Utah Health to recognition for its health care delivery system innovations [36] that enable higher quality at lower costs [37] [38] [39] and with higher patient satisfaction, [40] [41] [42] [43] as well as successful strategies of faculty development and mentorship. [44] [45] In 2012, the University of Utah become the first health system in the country to post patient reviews online. [46]

In 2016, University of Utah was ranked first among university hospitals in quality and safety, [47] with NYU Langone and Mayo Clinic rounding out the top three. That year marked the 7th consecutive year that the University of Utah was ranked in the top 10 in quality in the nation. The university's health insurance plan acquired a commercial license, grew five-fold, and was successful in the individual exchange. Improved financial performance of the clinical enterprise enabled increased support and growth of education, research, and community service initiatives.

As dean, Lee led the significant expansion of the school of medicine class size from 82 to 125 students per year with increased ongoing state funding. [48] A number of significant philanthropic commitments were made during her tenure, including the establishment of a new Rehabilitation Hospital, [49] funding for a number of research initiatives including the Utah Genome Project, [50] the Center for Medical Innovation, [51] and Driving Out Diabetes: A Larry H. Miller Family Foundation Wellness Initiative, [52] as well as both private and state funding for a new School of Medicine building. [53] During her tenure, the University of Utah's health sciences budget grew 50 percent to over $3.5 billion.

Huntsman Cancer Institute controversy

Lee became embroiled in a public controversy when University leadership fired Huntsman Cancer Institute CEO, Mary Beckerle, on April 17, 2017. Lee and university leadership were publicly criticized for the move by HCI's founder and prime benefactor, billionaire philanthropist Jon Huntsman, Sr. [54] The decision prompted public protests by University of Utah faculty and staff, [55] including an online petition calling for University leadership to reverse the decision and reinstate Beckerle. [56] Jon Huntsman, Sr., publicly called for Lee and University President David W. Pershing to be fired from their leadership positions on April 21, 2017, [57] [58] questioning their ethics and predicting that the governor and state legislature would become involved to ensure their removal. [59] On April 22, 2017, the Editorial Board of the Salt Lake Tribune (a newspaper owned by a member of the Huntsman family) called for Lee's removal as the "only remedy in this case." [60] The University Board of Trustees met with Pershing and Lee on April 25, 2017. [61] Within hours after the meeting, Pershing released a written statement announcing that Beckerle was immediately resuming her service as CEO and Director of Huntsman Cancer Institute and would report directly to the President of the University. [62] [63] [64] Pershing's announcement signaled that Lee would no longer oversee the Huntsman Cancer Institute, raising questions about the future direction of the University Health system. [65]

Huntsman stated that a planned donation of $250M dollars would have been withheld unless the university's decision was reversed and Beckerle reinstated. On 28 April, Lee announced via email that, effective the same day, she was stepping down as the university's senior vice president for health sciences, dean of the medical school, and CEO of the healthcare system. [66] [67]

After her resignation, local reporters at the Deseret News discovered more details about the dispute over finances with Huntsman Cancer Institute, including demands for substantial increases in financial transfers from the University to the Huntsman Cancer Institute. [68]

Verily Health Platforms

From 2018 to 2022, Lee served as President of Health Platforms at Verily, an Alphabet company. As the founding leader of health platforms, she helped to launch and grow several new successful businesses in areas of digital health, precision risk insurance, healthcare analytics, mental and behavioral health, and pandemic management, with substantial year-over-year growth during her tenure. She announced her departure at the end of 2022 to move to Harvard University to focus on the intersection of tech, climate change and health care, with the aim of building more resilient systems for the future.

Awards and recognition

In her academic career Lee was awarded a Rhodes Scholarship to study at Balliol College, Oxford, and was recognized as one of Crain's "40 Under 40." In 2009, she received the Chang-Lin Tien Leadership award. [69] She was elected to the American Society of Clinical Investigation in 2015 and to the National Academy of Medicine in October 2015. [70] In 2019 she received the gold medal, the highest award from the International Society for Magnetic Resonance in Medicine. Modern Healthcare listed her among the 100 Most Influential People in Healthcare, ranking her at No. 11.

Related Research Articles

<span class="mw-page-title-main">Magnetic resonance imaging</span> Medical imaging technique

Magnetic resonance imaging (MRI) is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes inside the body. MRI scanners use strong magnetic fields, magnetic field gradients, and radio waves to generate images of the organs in the body. MRI does not involve X-rays or the use of ionizing radiation, which distinguishes it from computed tomography (CT) and positron emission tomography (PET) scans. MRI is a medical application of nuclear magnetic resonance (NMR) which can also be used for imaging in other NMR applications, such as NMR spectroscopy.

Endorectal coil magnetic resonance imaging or endorectal coil MRI is a type of medical imaging in which MRI is used in conjunction with a coil placed into the rectum in order to obtain high quality images of the area surrounding the rectum. The technique has demonstrated higher accuracy than other modalities in assessing seminal vesicle invasion and extra-capsular extension (ECE) of prostate cancer. Endorectal coil MRI is useful for determining the extent of spread and local invasion of cancers of the prostate, rectum, and anus. The coil consists of a probe with an inflatable balloon which helps maintain appropriate positioning. Similar coils may be used vaginally for evaluating cervical cancer.

<span class="mw-page-title-main">Breast MRI</span> Form of breast imaging

One alternative to mammography, breast MRI or contrast-enhanced magnetic resonance imaging (MRI), has shown substantial progress in the detection of breast cancer.

Magnetic resonance elastography (MRE) is a form of elastography that specifically leverages MRI to quantify and subsequently map the mechanical properties of soft tissue. First developed and described at Mayo Clinic by Muthupillai et al. in 1995, MRE has emerged as a powerful, non-invasive diagnostic tool, namely as an alternative to biopsy and serum tests for staging liver fibrosis.

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based contrast agents (GBCAs). Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.

<span class="mw-page-title-main">Gadoteridol</span> Chemical compound

Gadoteridol (INN) is a gadolinium-based MRI contrast agent, used particularly in the imaging of the central nervous system. It is sold under the brand name ProHance. Gadoteridol was first approved for use in the United States in 1992.

<span class="mw-page-title-main">University of Utah School of Medicine</span> Medical school of the University of Utah

The University of Utah School of Medicine is located on the upper campus of the University of Utah in Salt Lake City, Utah. It was founded in 1905 and is currently the only MD-granting medical school in the state of Utah.

An imaging biomarker is a biologic feature, or biomarker detectable in an image. In medicine, an imaging biomarker is a feature of an image relevant to a patient's diagnosis. For example, a number of biomarkers are frequently used to determine risk of lung cancer. First, a simple lesion in the lung detected by X-ray, CT, or MRI can lead to the suspicion of a neoplasm. The lesion itself serves as a biomarker, but the minute details of the lesion serve as biomarkers as well, and can collectively be used to assess the risk of neoplasm. Some of the imaging biomarkers used in lung nodule assessment include size, spiculation, calcification, cavitation, location within the lung, rate of growth, and rate of metabolism. Each piece of information from the image represents a probability. Spiculation increases the probability of the lesion being cancer. A slow rate of growth indicates benignity. These variables can be added to the patient's history, physical exam, laboratory tests, and pathology to reach a proposed diagnosis. Imaging biomarkers can be measured using several techniques, such as CT, PET, SPECT, ultrasound, electroencephalography, magnetoencephalography, and MRI.

Thomas M. Kolb is an American radiologist specializing in the detection and diagnosis of breast cancer in young, predominantly high-risk premenopausal women. He has served as an assistant clinical professor of Radiology at Columbia University College of Physicians and Surgeons from 1994–2010. Kolb is double board certified, having received his training in pediatrics at the Albert Einstein College of Medicine in Bronx, New York, and in diagnostic radiology at the Columbia-Presbyterian Medical Center in New York.

<span class="mw-page-title-main">Mary Beckerle</span> American cell biologist

Mary C. Beckerle is an American cell biologist who studies cancer at the Huntsman Cancer Institute at the University of Utah School of Medicine. At Huntsman Cancer Institute, she serves as the CEO and also as Associate Vice President for Cancer Affairs at the University of Utah. Beckerle's research helped to define a novel molecular pathway for cell motility, and more recently, she has begun research into Ewing’s sarcoma, a pediatric bone cancer. Beckerle's lab made a ground breaking discovery in regards to Ewing's Sarcoma in relation to the EWS/FLI protein. Her lab discovered EWS/FLI to disrupt the internal cellular skeleton, which decreases the ability of cells to adhere to their proper environment. This can help explain the metastasis of tumors in patients with Ewing's sarcoma.

<span class="mw-page-title-main">Breast imaging</span>

In medicine, breast imaging is a sub-speciality of diagnostic radiology that involves imaging of the breasts for screening or diagnostic purposes. There are various methods of breast imaging using a variety of technologies as described in detail below. Traditional screening and diagnostic mammography uses x-ray technology and has been the mainstay of breast imaging for many decades. Breast tomosynthesis is a relatively new digital x-ray mammography technique that produces multiple image slices of the breast similar to, but distinct from, computed tomography (CT). Xeromammography and galactography are somewhat outdated technologies that also use x-ray technology and are now used infrequently in the detection of breast cancer. Breast ultrasound is another technology employed in diagnosis and screening that can help differentiate between fluid filled and solid lesions, an important factor to determine if a lesion may be cancerous. Breast MRI is a technology typically reserved for high-risk patients and patients recently diagnosed with breast cancer. Lastly, scintimammography is used in a subgroup of patients who have abnormal mammograms or whose screening is not reliable on the basis of using traditional mammography or ultrasound.

In the field of medicine, radiomics is a method that extracts a large number of features from medical images using data-characterisation algorithms. These features, termed radiomic features, have the potential to uncover tumoral patterns and characteristics that fail to be appreciated by the naked eye. The hypothesis of radiomics is that the distinctive imaging features between disease forms may be useful for predicting prognosis and therapeutic response for various cancer types, thus providing valuable information for personalized therapy. Radiomics emerged from the medical fields of radiology and oncology and is the most advanced in applications within these fields. However, the technique can be applied to any medical study where a pathological process can be imaged.

<span class="mw-page-title-main">LI-RADS</span> LI Rads for the Classification of HCC

The Liver Imaging Reporting and Data System is a quality assurance tool created and trademarked by the American College of Radiology in 2011 to standardize the reporting and data collection of CT and MR imaging patients at risk for hepatocellular carcinoma (HCC), or primary cancer of the liver cells. It provides a standardized framework for classification of liver lesions by a radiologist, and only applies in patients with chronic liver disease, the main risk factor for liver cancer. The hierarchical classification, from LR1 to LR5, is based on specific imaging features of the lesion in question, and corresponds to the degree of suspicion for malignancy. For example, a lesion with features corresponding to the highest category, LR5, is "definitely" HCC. Importantly, the increasing acceptance of the LI-RADS system of reporting by referring clinicians has reduced the need for tissue biopsy confirmation of cancer in patients with chronic liver disease.

Fiona Jane Gilbert is a Scottish radiologist and academic.

<span class="mw-page-title-main">Christiane K. Kuhl</span> Radiology scientist (born 1966)

Christiane K. Kuhl is a German scientist at RWTH Aachen University. She is Head of the Department of Radiology.

Nola M. Hylton is an American oncologist who is Professor of Radiology and Director of the Breast Imaging Research Group at the University of California, San Francisco. She pioneered the usage of magnetic resonance imaging for the detection, diagnosis, and staging of breast cancer by using MRIs to locate tumors and characterize the surrounding tissue.

Luis Marti-Bonmati is a Spanish professor and researcher. He is the director of the Clinical Area of Medical Imaging Department at La Fe Polytechnic and University Hospital, and Head of Radiology Department at QuironSalud Hospital, Valencia, Spain. Marti-Bonmati is the founder of QUIBIM S.L., and is the Director of its Scientific Advisory Board. He is a member of the Spanish National Royal Academy of Medicine. He is also the director of the Biomedical Imaging Research Group (GIBI230) at La Fe Health Research Institute. The group is now included in the Imaging La Fe node at Distributed Network for Biomedical Imaging (ReDIB) Unique Scientific and Technical Infrastructures (ICTS), Valencia, Spain.

Denis Le Bihan is a medical doctor, physicist, member of the Institut de France, member of the French Academy of Technologies and director since 2007 of NeuroSpin, an institution of the Atomic Energy and Alternative Energy Commission (CEA) in Saclay, dedicated to the study of the brain by magnetic resonance imaging (MRI) with a very high magnetic field. Denis Le Bihan has received international recognition for his outstanding work, introducing new imaging methods, particularly for the study of the human brain, as evidenced by the many international awards he has received, such as the Gold Medal of the International Society of Magnetic Resonance in Medicine (2001), the coveted Lounsbery Prize, the Louis D. Prize from the Institut de France, the prestigious Honda Prize (2012), the Louis-Jeantet Prize (2014), the Rhein Foundation Award (2021). His work has focused on the introduction, development and application of highly innovative methods, notably diffusion MRI.

Daniel Kevin Sodickson is an American physicist and an expert in the field of biomedical imaging. A past president and gold medalist of the International Society for Magnetic Resonance in Medicine, he is credited with foundational work in parallel magnetic resonance imaging (MRI), in which distributed arrays of detectors are used to gather magnetic resonance images at previously inaccessible speeds. Sodickson is an elected Fellow of the US National Academy of Inventors. He currently serves as Vice-Chair for Research in the Department of Radiology at New York University (NYU) Grossman School of Medicine, as Director of the department's Bernard and Irene Schwartz Center for Biomedical Imaging, as Principal Investigator of the Center for Advanced Imaging Innovation and Research, and as Co-Director of NYU's Tech4Health Institute.

<span class="mw-page-title-main">Rachel Brem</span> American radiologist and physician

Rachel F. Brem is an American diagnostic radiologist, professor of radiology at the George Washington University School of Medicine & Health Sciences, and director of the Breast Imaging and Interventional Center at George Washington University’s Cancer Center. She previously served as director of Breast Imaging at Johns Hopkins. Brem develops novel technologies to better support early diagnosis and treatment of breast cancer. She is a fellow of the American College of Radiology and the Society of Breast Imaging.

References

  1. ↑ "About IHI". Ihi.org. Retrieved July 16, 2018.
  2. ↑ "100 Most Influential People in Healthcare – 2019". Modern Healthcare. February 6, 2019. Retrieved June 19, 2020.
  3. ↑ "Vivian Lee, M.D., Ph.D., M.B.A." Ismrm.org. Retrieved July 16, 2018.
  4. ↑ [ dead link ]
  5. ↑ "High Honor for the U of U Medical School's Vivian S. Lee, Mario R. Capecchi: Election to the National Academy of Medicine – University of Utah Health". Healthcare.utah.edu. Retrieved July 16, 2018.
  6. ↑ "Vivian S. Lee, MD, PhD, MBA" Archived December 9, 2012, at the Wayback Machine , University of Utah Health, Salt Lake City, UT, Retrieved on March 14, 2017.
  7. ↑ "Massachusetts General Hospital, Boston, Massachusetts – Massachusetts General Hospital, Boston, MA". Massgeneral.org. Retrieved July 16, 2018.
  8. ↑ "External Advisory Board". Center for Health Incentives and Behavioral Economics. Retrieved May 6, 2022.
  9. ↑ "Editors and Publishers | About NEJM Catalyst". catalyst.nejm.org. Retrieved June 19, 2020.
  10. ↑ "Benedict Kingsbury – Overview – NYU School of Law". its.law.nyu.edu. Retrieved July 16, 2018.
  11. 1 2 Maffly, Brian. "University of Utah's new health science chief has high hopes for flagship's future", The Salt Lake Tribune , Salt Lake City, UT, January 2, 2012. Retrieved on March 14, 2017.
  12. ↑ "Tales in Possible : Celebrate Possible 2017 Executive MBA Graduation Ceremony". Stern.nyu.edu. Retrieved March 31, 2018.
  13. ↑ Lee, VS; Rusinek, H; Johnson, G; Rofsky, NM; Krinsky, GA; Weinreb, JC (2001). "MR renography with low-dose gadopentetate dimeglumine: feasibility". Radiology. 221 (2): 371–379. doi:10.1148/radiol.2212010142. PMID   11687678.
  14. ↑ Lee, VS; Rusinek, H; Noz, M; Lee, P; Raghavan, M; Kramer, EL (2003). "Dynamic three-dimensional MR renography for the measurement of single kidney function—Initial experience". Radiology. 227 (1): 289–294. doi:10.1148/radiol.2271020383. PMID   12615998. S2CID   5153542.
  15. ↑ Zhang, JL; Rusinek, H; Bokacheva, L; Lim, RP; Chen, Q; Storey, P; Prince, K; Hecht, EM; Kim, DC; Lee, VS (2009). "Angiotensin-converting enzyme inhibitor-enhanced MR renography: repeated measures of GFR and RPF in hypertensive patients". Am J Physiol Renal Physiol. 296 (4): F884-91. doi:10.1152/ajprenal.90648.2008. PMC   2670643 . PMID   19158343.
  16. ↑ Yamamoto, A; Zhang, JL; Rusinek, H; Chandarana, H; Babb, J; Diflo, T; John, D; Benstein, J; Barisoni, L; Vivier, PH; Stoffel, D; Lee, VS (2011). "Quantitative evaluation of acute renal transplant dysfunction with low-dose 3D MR renography". Radiology. 260 (3): 781–9. doi:10.1148/radiol.11101664. PMC   3157004 . PMID   21771953.
  17. ↑ Vivier, PH; Storey, P; Rusinek, H; Zhang, JL; Yamamoto, A; Tantillo, K; Khan, U; Lim, RP; Babb, JS; John, D; Teperman, LW; Chandarana, H; Friedman, K; Benstein, JA; Skolnik, EY; Lee, VS (2011). "Kidney function: Glomerular filtration rate measurement with MR renography in patients with cirrhosis". Radiology. 259 (2): 462–70. doi:10.1148/radiol.11101338. PMC   6939953 . PMID   21386050.
  18. ↑ Zhang, Jeff L.; Morrell, Glen; Rusinek, Henry; Warner, Lizette; Vivier, Pierre-Hugues; Cheung, Alfred K.; Lerman, Lilach O.; Lee, Vivian S. (2014). "Measurement of renal tissue oxygenation with blood oxygen level-dependent MRI and oxygen transit modeling". American Journal of Physiology. Renal Physiology. 306 (6): F579–F587. doi:10.1152/ajprenal.00575.2013. PMC   3949039 . PMID   24452640.
  19. ↑ Lee, VS; Rusinek, H; Bokacheva, L; Huang, AJ; Oesingmann, N; Chen, Q; Kaur, M; Prince, K; Song, T; Kramer, EL; Leonard, EF (2007). "Renal function measurements from MR renography and a multicompartmental model". Am J Physiol Renal Physiol.
  20. ↑ Krinsky, GA; Lee, VS; Theise, ND; Weinreb, JC; Rofsky, NM; Diflo, T; Teperman, LW (2001). "Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and transplant correlation". Radiology. 219 (2): 445–454. doi:10.1148/radiology.219.2.r01ma40445. PMID   11323471.
  21. ↑ Pandharipande, PV; Lee, VS; Reuss, PM; Charles, HW; Rosen, RJ; Rofsky, NM (2002). "Two-station bolus-chase MR angiography with a stationary table: A simple alternative to automated-table techniques". American Journal of Roentgenology. 179 (6): 1583–1589. doi:10.2214/ajr.179.6.1791583. PMID   12438059.
  22. ↑ Shinde TS, Lee VS, Rofsky NM, Krinsky GA, Weinreb JC. Three-dimensional gadolinium-enhanced MR venographic evaluation of central veins in the thorax: Initial experience Radiology 1999; 213:555–560.
  23. ↑ Lee, VS; Krinsky, GA; Nazzaro, CA; Chang, JS; Babb, JS; Lin, JC; Morgan, GR; Teperman, LW (2004). "Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography". Radiology. 233 (3): 659–666. doi:10.1148/radiol.2333031977. PMID   15516606.
  24. ↑ Israel, GM; Lee, VS; Edye, M; Krinsky, GA; Lavelle, MT; Diflo, T; Weinreb, JC (2002). "Comprehensive MR imaging evaluation of living donor candidates of laparoscopic nephrectomy: Initial experience". Radiology. 225 (2): 427–432. doi:10.1148/radiol.2252011671. PMID   12409576.
  25. ↑ Lee, VS; Resnick, D; Bundy, JM; Simonetti, OP; Lee, P; Weinreb, JC (2002). "Cardiac function: MR evaluation in one breath hold with real-time true fast imaging with steady-state precession". Radiology. 222 (3): 835–842. doi:10.1148/radiol.2223011156. PMID   11867810.
  26. ↑ Lee, VS; Resnick, D; Tiu, SS; Sanger, JJ; Nazzaro, CA; Israel, GM; Simonetti, OP (2004). "MR imaging evaluation of myocardial viability in the setting of equivocal SPECT results with 99mTc sestamibi". Radiology. 230 (1): 191–197. doi:10.1148/radiol.2301030070. PMID   14617765.
  27. ↑ Miyazaki, M; Lee, VS (2008). "Non-enhanced MR angiography: State-of-the-Art". Radiology. 248 (1): 20–43. doi:10.1148/radiol.2481071497. PMID   18566168.
  28. ↑ Lim, RP; Fan, Z; Chatterji, M; Baadh, A; Atanasova, IP; Storey, P; Kim, DC; Kim, S; Hodnett, PA; Ahmad, A; Stoffel, DR; Babb, JS; Adelman, MA; Xu, J; Li, D (2013). "Lee VS. Comparison of non-contrast-enhanced MRA subtraction techniques for the infragenual arteries at 1.5 T: A Preliminary Study". Radiology. 267 (1): 293–304. doi:10.1148/radiol.12120859. PMC   3606542 . PMID   23297320.
  29. ↑ Storey, P; Otazo, R; Lim, RP; Kim, S; Fleysher, L; Oesingmann, N; Lee, VS; Sodickson, DK (2012). "Exploiting sparsity to accelerate noncontrast MR angiography in the context of parallel imaging". Magn Reson Med. 67 (5): 1391–1400. doi:10.1002/mrm.23132. PMC   3291797 . PMID   22081482.
  30. 1 2 "Blue Ridge Institute for Medical Research". brimr.org. Retrieved March 31, 2018.
  31. ↑ "Siemens 7 Tesla Whole Body MRI : Radiology". Med.nyu.edu. Archived from the original on April 1, 2018. Retrieved March 31, 2018.
  32. ↑ "NYU Langone Medical Center Receives $100 Million Gift to Establish Neuroscience Institute". nyulangone.org. Retrieved March 31, 2018.
  33. ↑ "$29.4M Grant Establishes Clinical And Translational Science Institute At NYU In Partnership With NYC Health And Hospitals". Bioprocessonline.com. Retrieved March 31, 2018.
  34. ↑ "Re:Search Report 2008" (PDF). Nyulangone.org. Archived from the original (PDF) on June 10, 2016. Retrieved July 16, 2018.
  35. ↑ Leonard, Wendy (April 8, 2015). "Utah's first academic dental school is up and running". DeseretNews.com. Archived from the original on August 11, 2015. Retrieved April 19, 2018.
  36. ↑ "Home – Algorithms for Innovation". uofuhealth.utah.edu. Retrieved April 19, 2018.
  37. ↑ Lee, Vivian S.; Kawamoto, Kensaku; Hess, Rachel; Park, Charlton; Young, Jeffrey; Hunter, Cheri; Johnson, Steven; Gulbransen, Sandi; Pelt, Christopher E. (September 13, 2016). "Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality". JAMA. 316 (10): 1061–72. doi: 10.1001/jama.2016.12226 . ISSN   0098-7484. PMID   27623461.
  38. ↑ Porter, Michael E.; Lee, Thomas H. (September 13, 2016). "From Volume to Value in Health Care". JAMA. 316 (10): 1047–8. doi:10.1001/jama.2016.11698. ISSN   0098-7484. PMID   27623459.
  39. ↑ Kolata, Gina (September 7, 2015). "What Are a Hospital's Costs? Utah System Is Trying to Learn". The New York Times. ISSN   0362-4331 . Retrieved April 19, 2018.
  40. ↑ "Doctors Strive to Do Less Harm by Inattentive Care". The New York Times. February 17, 2015. ISSN   0362-4331 . Retrieved April 19, 2018.
  41. ↑ "Online Reviews Could Help Fix Medicine". Harvard Business Review. June 3, 2014. Retrieved April 19, 2018.
  42. ↑ "Engaging Doctors in the Health Care Revolution". Harvard Business Review. June 1, 2014. Retrieved April 19, 2018.
  43. ↑ Lee, Vivian (January 19, 2017). "Transparency and Trust — Online Patient Reviews of Physicians". New England Journal of Medicine. 376 (3): 197–199. doi:10.1056/NEJMp1610136. ISSN   0028-4793. PMID   28099823.
  44. ↑ Byington C, Keenan H, Phillips JD, Childs R, Wachs E, Berzins MA, Clark K, Torres MK, Abramson J, Lee VS, Clark EB. A matrix mentoring model effectively supports clinical and translational scientists and increases inclusion in biomedical research. Acad Med. 2016; 91(4):497–502.
  45. ↑ Byington, CL; Lee, VS (2015). "Addressing disparities in academic medicine moving forward". JAMA. 314 (11): 1139–1141. doi:10.1001/jama.2015.10664. PMID   26372582.
  46. ↑ Lee, Thomas H. (June 3, 2014). "Online Reviews Could Help Fix Medicine". Harvard Business Review. Retrieved July 16, 2018.
  47. ↑ "Vizient, Inc. Presents the Bernard A. Birnbaum, MD, Quality Leadership Award to 27 Top-performing Academic Medical Centers and Community Hospitals". newsroom.vizientinc.com. Retrieved April 19, 2018.
  48. ↑ "First expanded class of medical students welcomed to U of U". KSL.com. Retrieved April 19, 2018.
  49. ↑ Stilson, Ashley (November 1, 2017). "U. health officials celebrate new rehabilitation center". DeseretNews.com. Retrieved April 19, 2018.
  50. ↑ Zhang, Sarah. "What Mormon Family Trees Tell Us About Cancer". The Atlantic. Retrieved April 19, 2018.
  51. ↑ Innovation, University of Utah, Center for Medical. "University of Utah Center for Medical Innovation's Bench to Bedside Program Completes 7th Year with Presentation of 39 New Medical Technologies". Prnewswire.com (Press release). Retrieved April 19, 2018.{{cite press release}}: CS1 maint: multiple names: authors list (link)
  52. ↑ "Miller Family donates $5.3M to UofU Hospital to fight diabetes". The Salt Lake Tribune. Retrieved April 19, 2018.
  53. ↑ Cortez, Marjorie (January 22, 2017). "2017 Legislature preview: New U. med school, funds for growth top higher education needs, officials say". DeseretNews.com. Retrieved April 19, 2018.
  54. ↑ "Huntsman Sr. blasts the U. for firing of Cancer Institute director, says there is 'no excuse' for it". KSL.com. Retrieved April 19, 2017.
  55. ↑ "Top Researcher's Departure Prompts Faculty Protest at U. of Utah Institute". Chronicle.com. Retrieved April 20, 2017.
  56. ↑ "Power struggle erupts at Utah cancer institute over director's firing". Sciencemag.org. Retrieved April 20, 2017.
  57. ↑ "Jon Huntsman Sr. weighs in as protests continue over firing of CEO at Huntsman Cancer Institute". Fox13now.com. Retrieved April 22, 2017.
  58. ↑ "Huntsman calls for 'inept' U. administrators to be fired over cancer institute CEO's termination". Sltrib.com. Retrieved April 22, 2017.
  59. ↑ "Conversation with Cancer Letter". Cancerletter.com. Retrieved April 22, 2017.(subscription required)
  60. ↑ "Tribune Editorial: It is time for new leadership at the University of Utah and its Health Sciences colleges". Sltrib.com. Retrieved April 22, 2017.
  61. ↑ "University Shifts Course, Reinstating Head Of Huntsman Cancer Institute". Kuer.org. Retrieved April 25, 2017.
  62. ↑ "Cancer institute reinstates director after uproar from staff and funder". Sciencemag.org. Retrieved April 25, 2017.
  63. ↑ "After a Week of Protest, U. of Utah Cancer Researcher Is Reinstated". Chronicle.com. Retrieved April 25, 2017.
  64. ↑ "After protests, a fired cancer center director gets her job back". Statnews.com. Retrieved April 25, 2017.
  65. ↑ "What now? Rift exposes tensions in University of Utah health care system". Deseretnews.com. Archived from the original on April 26, 2017. Retrieved April 26, 2017.
  66. ↑ "U. Health Care CEO Vivian Lee resigns after cancer institute controversy". Sltrib.com. Retrieved July 16, 2018.
  67. ↑ "Dr. Vivian Lee resigns post at University of Utah - KSL.com". Ksl.com. Retrieved July 16, 2018.
  68. ↑ "The inside story: Power and money at center of U. controversy". Deseretnews.com. Archived from the original on May 2, 2017. Retrieved May 6, 2017.
  69. ↑ Education Leadership Award, Chang-Lin Tien. "Vivian Lee". Archived from the original on June 26, 2015. Retrieved March 15, 2017.
  70. ↑ "NAM Elects 80 New Members", National Academy of Medicine , October 19, 2015. Retrieved on March 14, 2017.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.